LifeVantage

LifeVantage Corp. engages in the identification, research, development and distribution of advanced nutraceutical dietary supplements and personal care products. The firm operates through the following geographical segments: Americas Region, and Asia/Pacific and Europe Region. Its products include Protandim, LifeVantage Omega+ and ProBio, TrueScience and Petandim for dogs. The company was founded in June 1988 and is headquartered in Sandy, UT.

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Earnings data Q1 2025

Earnings data Q2 2025

LifeVantage reports 7.5% revenue growth, eyes expansion into new markets

LifeVantage's Q1 2023 results reflect strong revenue growth driven by the Americas region and successful product launches. The company's LV360 initiative and new compensation plan have shown promising results. However, challenges in the Asia Pacific and Europe region need to be addressed. The fiscal 2023 outlook presents opportunities for continued growth and expansion into new markets.

LifeVantage reports revenue growth in Q2, driven by LV360 strategy

LifeVantage's Q2 saw revenue growth, improved engagement, and successful resolution of supply chain challenges. The introduction of LV360 and product innovations drove performance. Challenges in supply chain management persist, but opportunities for growth are present.

LifeVantage reports revenue growth and product innovation in Q3

LifeVantage's Q3 performance reflects revenue growth, strong financials, and product innovation, with a focus on market expansion.
While challenges exist in regional revenue declines and market uncertainties, the company's strengths in the Americas region and product launches offer growth opportunities.
Maintaining financial stability, enhancing consultant growth, and leveraging new products position LifeVantage for continued success and market leadership.
Overall, LifeVantage's strategic initiatives and financial performance indicate a resilient business model with growth potential and shareholder value.

LifeVantage reports strong Q4 earnings, unveils special dividend for shareholders

LifeVantage's Q4 2023 results reflect robust revenue growth and improved profitability, driven by strategic initiatives and product performance. The company's commitment to shareholder value through dividends and its transformation plan underscores a positive outlook for future growth. While challenges exist, opportunities in product innovation and market expansion position LifeVantage well for continued success.

LifeVantage posts robust Q1 results, eyes international growth opportunities

LifeVantage delivered a strong Q1 2024 performance with revenue growth and improved profitability, driven by successful product sales and international expansion.
Despite challenges like currency fluctuations, the company's financial stability, strategic capital allocation, and growth outlook position it well for future success.
Opportunities in product innovation, international markets, and strategic investments underscore potential avenues for continued growth and value creation for shareholders.
Investors can be optimistic about LifeVantage's trajectory, supported by its solid financial foundation and clear strategic focus on maximizing shareholder value.

LifeVantage reports strong Q2 earnings, eyes growth through product innovation

LifeVantage showcased robust financial performance with notable EBITDA growth and revenue per consultant increase, despite a slight revenue decline.
The company's focus on product innovation, market expansion, and shareholder value enhancement positions it well for future growth and competitiveness.
Strategies to address revenue challenges, capitalize on growth opportunities, and navigate market dynamics will be crucial for sustained success.

LifeVantage reports robust Q3 performance amidst revenue challenges and growth opportunities

LifeVantage demonstrated strong operational performance and profitability improvements in Q3, despite revenue challenges.
The company's focus on consultant enrollment, new product launches, and financial stability are key strengths.
While facing revenue and margin pressures, LifeVantage has opportunities to drive growth through market expansion and product optimization.
Strategic initiatives to address challenges and capitalize on opportunities will be crucial for sustained success in future quarters.

LifeVantage reports Q4 results, eyes growth with loyalty programs

LifeVantage's Q4 2024 performance showed revenue decline but improved margins and strategic initiatives.
Strengths lie in loyalty program enhancements, positive financials, and a promising outlook for fiscal 2025.
Challenges include leadership changes, revenue decline, and the need for sustained growth in active accounts.
Opportunities exist in product launches, retention strategies, and market expansion for the company's growth.
headline

LifeVantage reports robust Q1 earnings, eyes international expansion for growth

LifeVantage's Q1 2025 showcased strong profitability despite revenue decline, driven by the successful MindBody GLP-1 System launch.
Guidance for fiscal 2025 indicates a positive outlook with revenue and EBITDA projections, supported by plans for international product expansion.
While facing revenue challenges, the company's focus on innovation, market demand, and strategic growth initiatives present opportunities for future success.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

LifeVantage Corp. engages in the identification, research, development, formulation, and sale of nutraceutical dietary supplements and personal care products. Its products include Protandim, Axio, TrueScience, PhysIQ, and Petandim. It operates through the Americas, and Asia or Pacific and Europe geographical segments. The company was founded in June 1988 and is headquartered in Lehi, UT.

LifeVantage Corporation (NASDAQ:LFVN ) Q4 2023 Earnings Conference Call August 28, 2023 4:30 PM ET Company Participants Reed Anderson - ICR Steve Fife - President and CEO Carl Aure - CFO Conference Call Participants Operator Good day, ladies and gentlemen. Thank you for standing by.

LifeVantage Corporation (LFVN) Q4 2023 Earnings Call Transcript

SALT LAKE CITY, Aug. 28, 2023 (GLOBE NEWSWIRE) --  LifeVantage Corporation (Nasdaq: LFVN) a leading health and wellness company with products designed to activate optimal health processes, today reported financial results for its fourth quarter and full fiscal year ended June 30, 2023. Fourth Quarter Fiscal 2023 Summary*: Revenue of $54.2 million, an increase of 6.4% from the prior year period.

LifeVantage Announces Financial Results for the Fourth Fiscal Quarter and Full Fiscal Year 2023

SALT LAKE CITY, Aug. 28, 2023 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq:LFVN) a leading health and wellness company with products designed to activate optimal health processes, today announced that the Company's Board of Directors has declared a special one-time cash dividend of $0.40 per share of common stock, which will be paid September 22, 2023 to all stockholders of record at the close of business on September 8, 2023.

LifeVantage Declares Special Cash Dividend of $0.40 Per Share

SALT LAKE CITY, Aug. 14, 2023 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq:LFVN) a leading health and wellness company with products designed to activate optimal health processes, today announced that it will release financial results for its fourth quarter and full fiscal year ended June 30, 2023, after the stock market closes on Monday, August 28, 2023. The Company will hold a conference call for investors at 2:30 p.m. Mountain Time (4:30 p.m. Eastern Time) that same day.

LifeVantage to Announce Fourth Quarter and Full Fiscal Year 2023 Results on August 28, 2023

SALT LAKE CITY, July 12, 2023 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq: LFVN), a leading health and wellness company with products designed to activate optimal health processes, will visit the Nasdaq MarketSite in Times Square to celebrate the successful launch and implementation of the company's LV360 transformation initiatives. To honor the occasion, Steve Fife, President and Chief Executive Officer of LifeVantage, along with the company's executive staff and top Independent Consultants, have been invited to ring the Nasdaq closing bell on Friday, July 21.

LifeVantage to Ring the Nasdaq Stock Market Closing Bell

Differentiated Product Continues to Build Momentum with Consultants and Customers Differentiated Product Continues to Build Momentum with Consultants and Customers

TrueScience® Liquid Collagen Celebrates First Year with Continued Growth, Multiple Awards

SALT LAKE CITY, June 13, 2023 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq:LFVN) a leading health and wellness company with products designed to activate optimal health processes, today announced that the Company's Board of Directors has approved an extension to the previously authorized stock repurchase program extending it until December 31, 2026. Additionally, the Company announced that it has authorized a pre-arranged stock trading plan for the purpose of repurchasing a limited number of shares of the Company's common stock in accordance with the guidelines specified under Rule 10b5-1 of the Securities Exchange Act of 1934.

LifeVantage Extends Stock Repurchase Program

LFVN maintains a pristine balance sheet and currently trades with very low key multiples. Thanks to last week's dividend hike, the dividend yield is undoubtedly good.

LifeVantage: Dividend, Pristine Balance Sheet, Strong Upside Potential

LifeVantage Corporation (NASDAQ:LFVN ) Q3 2023 Earnings Conference Call May 4, 2023 4:30 PM ET Company Participants Reed Anderson - ICR Steve Fife - President and Chief Executive Officer Carl Aure - Chief Financial Officer Conference Call Participants Operator Good day, ladies and gentlemen. Thank you for standing by.

LifeVantage Corporation (LFVN) Q3 2023 Earnings Call Transcript

SALT LAKE CITY, May 04, 2023 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq: LFVN) today reported financial results for its third fiscal quarter ended March 31, 2023.

LifeVantage Announces Financial Results for the Third Quarter of Fiscal 2023

SALT LAKE CITY, May 04, 2023 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq:LFVN), a leading health and wellness company with products designed to activate optimal health processes, is proud to announce that TrueScience® Liquid Collagen has been named a recipient of the Bronze Stevie® Award in the Consumer Product category in the 21st Annual American Business Awards®.

TrueScience® Liquid Collagen Honored as Bronze Stevie® Award Winner in 2023 American Business Awards®

SALT LAKE CITY, April 20, 2023 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq:LFVN) announced today that it will release financial results for its third quarter ended March 31, 2023, after the stock market closes on Thursday, May 4, 2023. The Company will hold a conference call for investors at 2:30 p.m. Mountain Time (4:30 p.m. Eastern Time) that same day.

LifeVantage to Announce Third Quarter Fiscal Year 2023 Results on May 4, 2023

Launches Celebrated at “Evolve” Events Held in US, Japan, and Australia Markets Launches Celebrated at “Evolve” Events Held in US, Japan, and Australia Markets

LifeVantage Launches Evolve Compensation Plan, True Science® Liquid Collagen Internationally as LV360 Strategic Initiatives Continue to Gain Traction

LifeVantage Corporation (NASDAQ:LFVN ) Q2 2023 Earnings Conference Call February 2, 2023 4:30 PM ET Company Participants Reed Anderson - Investor Relations Steve Fife - President and Chief Executive Officer Carl Aure - Chief Financial Officer Operator Good day, ladies and gentlemen. Thank you for standing by.

LifeVantage Corporation (LFVN) Q2 2023 Earnings Call Transcript

SALT LAKE CITY, Feb. 02, 2023 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq: LFVN) today reported financial results for its second fiscal quarter ended December 31, 2022.

LifeVantage Announces Financial Results for the Second Quarter of Fiscal 2023

SALT LAKE CITY, Jan. 19, 2023 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq:LFVN) announced today that it will release financial results for its second quarter ended December 31, 2022, after the stock market closes on Thursday, February 2, 2023. The Company will hold a conference call for investors at 2:30 p.m. Mountain Time (4:30 p.m. Eastern Time) that same day.

LifeVantage to Announce Second Quarter Fiscal Year 2023 Results on February 2, 2023

LifeVantage Corporation (NASDAQ:LFVN ) Q1 2023 Results Conference Call November 2, 2022 4:30 PM ET Company Participants Reed Anderson - ICR Steven Fife - Chief Executive Officer Carl Aure - Chief Financial Officer Conference Call Participants Operator Good day, ladies and gentlemen. Thank you for standing by.

LifeVantage Corporation (LFVN) Q1 2023 Earnings Call Transcript

SALT LAKE CITY, Nov. 02, 2022 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq: LFVN) today reported financial results for its first fiscal quarter ended September 30, 2022.

LifeVantage Announces Financial Results for the First Quarter of Fiscal 2023

SALT LAKE CITY, Oct. 19, 2022 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq:LFVN) announced today that it will release financial results for its first quarter ended September 30, 2022, after the stock market closes on Wednesday, November 2, 2022. The Company will hold a conference call for investors at 2:30 p.m. Mountain Time (4:30 p.m. Eastern Time) that same day.

LifeVantage to Announce First Quarter Fiscal Year 2023 Results on November 2, 2022

The share price declined by almost 85% in 10 years. Revenue is stagnant as the management is more focused on share buybacks.

LifeVantage Corporation: Stagnant Sales But Strong Financials To Support The New Dividend

Andersons

Celularity

Clearway Energy

Investors may want to consider the following non-cyclical stocks as their earnings yields (as calculated by Joel Greenblatt (Trades, Portfolio)'s method) are outperforming the 20-year high-quality market corporate bond spot rate of 4.85% as of the time of writing.

4 Non-Cyclical Stocks With High Earnings Yields

LifeVantage Corporation (NASDAQ:LFVN ) Q4 2022 Earnings Conference Call August 23, 2022 4:30 PM ET Company Participants Reed Anderson - ICR Steve Fife - Chief Executive Officer Carl Aure - Chief Financial Officer Conference Call Participants Operator Good day, ladies and gentlemen. Thank you for standing by.

LifeVantage Corporation (LFVN) CEO Steve Fife on Q4 2022 Results - Earnings Call Transcript

SALT LAKE CITY, Aug. 23, 2022 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq: LFVN) today reported financial results for its fourth quarter and full fiscal year ended June 30, 2022.

LifeVantage Announces Financial Results for the Fourth Fiscal Quarter and Full Fiscal Year 2022

SALT LAKE CITY, Aug. 09, 2022 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq:LFVN) announced today that it will release financial results for its fourth quarter and full fiscal year ended June 30, 2022, after the stock market closes on Tuesday, August 23, 2022. The Company will hold a conference call for investors at 2:30 p.m. Mountain Time (4:30 p.m. Eastern Time) that same day.

LifeVantage to Announce Fourth Quarter and Full Fiscal Year 2022 Results on August 23, 2022

Rare Key Ingredient Red Quinoa Activates Natural Collagen Synthesis and Increases Collagen Density by 42% Rare Key Ingredient Red Quinoa Activates Natural Collagen Synthesis and Increases Collagen Density by 42%

News for LifeVantage Stock (LFVN)